Meyka Pro banner
Natera, Inc.

Natera, Inc. Fundamental Analysis (NASDAQ: NTRA)

NTRA●NASDAQ
HealthcareMedical - Diagnostics & Research
$314.20
$2.22(0.71%)
U.S. Market is Open · 10:42

Natera, Inc. Fundamental Analysis (NASDAQ: NTRA)

Natera, Inc. (NASDAQ: NTRA) shows moderate financial fundamentals with a PE ratio of -278.65, profit margin of -5.66%, and ROE of -9.18%. The company generates $2.9B in annual revenue with strong year-over-year growth of 35.90%.

Key Strengths

PEG Ratio-4.06
Current Ratio2.81

Areas of Concern

ROE-9.18%
Operating Margin-8.95%
Cash Position2.38%
We analyze NTRA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 35.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
35.8/100

We analyze NTRA's fundamental strength across five key dimensions:

Efficiency Score

Weak

NTRA struggles to generate sufficient returns from assets.

ROA > 10%
-5.99%

Valuation Score

Excellent

NTRA trades at attractive valuation levels.

PE < 25
-278.65
PEG Ratio < 2
-4.06

Growth Score

Moderate

NTRA shows steady but slowing expansion.

Revenue Growth > 5%
35.90%
EPS Growth > 10%
0.65%

Financial Health Score

Excellent

NTRA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.13
Current Ratio > 1
2.81

Profitability Score

Weak

NTRA struggles to sustain strong margins.

ROE > 15%
-917.95%
Net Margin ≥ 15%
-5.66%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is NTRA Expensive or Cheap?

P/E Ratio

NTRA trades at -278.65 times earnings. This suggests potential undervaluation.

-278.65

PEG Ratio

When adjusting for growth, NTRA's PEG of -4.06 indicates potential undervaluation.

-4.06

Price to Book

The market values Natera, Inc. at 24.48 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

24.48

EV/EBITDA

Enterprise value stands at -336.46 times EBITDA. This is generally considered low.

-336.46

How Well Does NTRA Make Money?

Net Profit Margin

For every $100 in sales, Natera, Inc. keeps $-5.66 as profit after all expenses.

-5.66%

Operating Margin

Core operations generate -8.95 in profit for every $100 in revenue, before interest and taxes.

-8.95%

ROE

Management delivers $-9.18 in profit for every $100 of shareholder equity.

-9.18%

ROA

Natera, Inc. generates $-5.99 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.99%

Following the Money - Real Cash Generation

Operating Cash Flow

Natera, Inc. generates limited operating cash flow of $214.17M, signaling weaker underlying cash strength.

$214.17M

Free Cash Flow

Natera, Inc. generates weak or negative free cash flow of $52.81M, restricting financial flexibility.

$52.81M

FCF Per Share

Each share generates $0.36 in free cash annually.

$0.36

FCF Yield

NTRA converts 0.11% of its market value into free cash.

0.11%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-278.65

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-4.06

vs 25 benchmark

P/B Ratio

Price to book value ratio

24.48

vs 25 benchmark

P/S Ratio

Price to sales ratio

15.84

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.13

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.81

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.09

vs 25 benchmark

ROA

Return on assets percentage

-0.06

vs 25 benchmark

ROCE

Return on capital employed

-0.12

vs 25 benchmark

How NTRA Stacks Against Its Sector Peers

MetricNTRA ValueSector AveragePerformance
P/E Ratio-278.6531.66 Better (Cheaper)
ROE-9.18%501.00% Weak
Net Margin-5.66%-3647.00% (disorted) Weak
Debt/Equity0.13-0.30 (disorted) Distorted
Current Ratio2.815.78 Strong Liquidity
ROA-5.99%-262.00% (disorted) Weak

NTRA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Natera, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

249.47%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

46.31%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

169.90%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ